CIK 0001789769 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Instil Bio, Inc.
Sign in to watch- Ticker
- TIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 832072195
- Phone
- (972) 499-3350
- Business address
- 3963 MAPLE AVENUE, SUITE 350, DALLAS, TX, 75219
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-23 | McGaughy R Kent Jr Director | Conversion | +954,182 | 8,028,790 | ||
| 2021-03-23 | McGaughy R Kent Jr Director | Purchase | +450,000 | $20.00 | $9.0M | 8,478,790 |
| 2021-03-23 | McGaughy R Kent Jr Director | Conversion · Series B Preferred Stock | −5,895,507 | 0 | ||
| 2021-03-23 | McGaughy R Kent Jr Director | Conversion · Series C Preferred Stock | −795,152 | 0 | ||
| 2021-03-23 | Curative Ventures V LLC 10% owner | Conversion | +30,000,000 | 30,000,000 | ||
| 2021-03-23 | Curative Ventures V LLC 10% owner | Conversion | +6,098,799 | 36,098,799 | ||
| 2021-03-23 | Curative Ventures V LLC 10% owner | Conversion | +1,431,274 | 37,530,073 | ||
| 2021-03-23 | Curative Ventures V LLC 10% owner | Purchase | +450,000 | $20.00 | $9.0M | 37,980,073 |
| 2021-03-23 | Curative Ventures V LLC 10% owner | Conversion · Series A Preferred Stock | −25,000,000 | 0 | ||
| 2021-03-23 | Curative Ventures V LLC 10% owner | Conversion · Series B Preferred Stock | −5,082,333 | 0 | ||
| 2021-03-23 | Curative Ventures V LLC 10% owner | Conversion · Series C Preferred Stock | −1,192,729 | 0 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion | +30,000,000 | 30,000,000 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion | +6,098,799 | 36,098,799 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion | +1,431,274 | 37,530,073 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Purchase | +450,000 | $20.00 | $9.0M | 37,980,073 |
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion · Series A Preferred Stock | −25,000,000 | 0 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion · Series B Preferred Stock | −5,082,333 | 0 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion · Series C Preferred Stock | −1,192,729 | 0 | ||
| 2021-03-18 | Shah Nimish P Director | Grant or award · Stock Option (right to buy) | +52,000 | 52,000 | ||
| 2021-03-18 | Roberts Zachary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +240,000 | 240,000 |
Page 5 of 6 · 108 trades